Updated on January 18, 2018
Follicum Identifies New Receptors That Affect Hair Growth
An interesting bit of news was released by the company Follicum this morning. In conjunction with a specialized research company Dualsystems Biotech, Follicum has identified receptors in hair follicle cells that their lead drug candidate FOL-005 binds to. This represents a viable mechanism of action for their product.
The press release mentions this information could be leveraged in Follicum’s discussions with regulatory authorities and commercial partners. I wonder if this information could also be leveraged to create new therapies for hair growth or improve upon their initial peptide formulation. I am impressed that Follicum continues to share worthwhile news regarding its progress and is moving towards a phase 2a trial for the scalp to begin first quarter this year. To read the full press release click here.